| Liraglutide-related cholelithiasis |
BryanPAacios |
Oct 3, 2015 4:39:41 AM |
| The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance |
BryanPAacios |
Oct 1, 2015 2:50:00 AM |
| Efficacy and safety of antihyperglycaemic drug regimens added to metformin and sulphonylurea therapy in Type 2 diabetes: a network meta-analysis |
BryanPAacios |
Oct 1, 2015 2:14:27 AM |
| GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK |
BryanPAacios |
Oct 1, 2015 1:45:41 AM |
| liraglutide 2015.pdf |
BryanPAacios |
Sep 25, 2015 2:53:20 AM |
| Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss |
BryanPAacios |
Sep 25, 2015 2:30:40 AM |
| Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms |
BryanPAacios |
Sep 25, 2015 2:25:51 AM |
| Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin |
BryanPAacios |
Sep 25, 2015 1:28:16 AM |
| Comparison Review of Short-Acting and Long-Acting Glucagon-like Peptide-1 Receptor Agonists |
BryanPAacios |
Sep 25, 2015 1:23:08 AM |
| Liraglutide in the treatment of obesity |
nmorales95 |
Sep 24, 2015 9:43:34 PM |
